The purpose of this study was to assess the value of genetic testing in addition to a comprehensive clinical evaluation, as part of the diagnostic work-up of elite and/or amateur Italian athletes referred for suspicion of inherited cardiac disease, following a pre-participation screening programme.
Methods
Between January 2009–December 2018, of 5892 consecutive participants, 61 athletes were investigated: 30 elite and 31 amateur athletes. Elite and amateur athletes were selected, on the basis of clinical suspicion for inherited cardiac disease, from two experienced centres for a comprehensive cardiovascular evaluation. Furthermore, the elite and amateur athletes were investigated for variants at DNA level up to 138 genes suspected to bear predisposition for possible cardiac arrest or even sudden cardiac death.
Results
Of these 61 selected subjects, six (10%) had diagnosis made possible by a deeper clinical evaluation, while genetic testing allowed a definite diagnosis in eight (13%). The presence of >3 clinical markers (i.e. family history, electrocardiogram and/or echocardiographic abnormalities, exercise-induced ventricular arrhythmias) was associated with a higher probability of positive genetic diagnosis (75%), compared with the presence of two or one clinical markers (14.2%, 8.1%, respectively, p-value = 0.004).
Conclusion
A combined clinical and genetic evaluation, based on the subtle evidence of clinical markers for inherited disease, was able to identify an inherited cardiac disease in about one-quarter of the examined athletes.
MaronBJ.Sudden death in young athletes. N Engl J Med2003;
349: 205–211.
2.
BurkeAPFarbAVirmaniR, et al.
Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J1991;
121: 568–575.
3.
MaronBJShiraniJPoliacLC, et al.
Sudden death in young competitive athletes: Clinical, demographic, and pathological profiles. J Am Med Assoc1996;
276: 199–204.
4.
MaronBJGohmanTEAeppliD.Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol1998;
32: 1881–1884.
5.
MaronBJCarneyKPLeverHM, et al.
Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol2003;
41: 974–980.
6.
CorradoDBassoCRizzoliG, et al.
Does sports activity enhance the risk of sudden death in adolescents and young adults?J Am Coll Cardiol2003;
42: 1959–1963.
7.
MaronBJThompsonPDPufferJC, et al.
Cardiovascular preparticipation screening of competitive athletes: A statement for health professionals from the Sudden Death Committee (Clinical cardiology) and Congenital Cardiac Defects Committee (Cardiovascular disease in the young), American Heart As. Circulation1996;
94: 850–856.
8.
CorradoDBassoCSchiavonM, et al.
Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med1998;
339:364–369.
9.
MaronBJZipesDPKovacsRJ.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, principles, and general considerations: A scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol2015;
66: 2343–2349.
10.
MontLPellicciaASharmaS, et al.
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol2017;
24: 41–69.
11.
VessellaTZorziAMerloL, et al.
The Italian preparticipation evaluation programme: Diagnostic yield, rate of disqualification and cost analysis. Br J Sports Med2020;
54: 231–237.
12.
CorradoDPellicciaAHeidbuchelH, et al.
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Hear J2010;
31: 243–259.
13.
MaronBJPellicciaA.The heart of trained athletes: Cardiac remodeling and the risks of sports, including sudden death. Circulation2006;
114: 1633–1644.
14.
FrissoGLimongelliGPacileoG, et al.
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy. Clin Genet2009;
76: 91–101.
15.
DettaNFrissoGLimongelliG, et al.
Genetic analysis in a family affected by sick sinus syndrome may reduce the sudden death risk in a young aspiring competitive athlete. Int J Cardiol2014;
170: e63–e65.
16.
SarubbiBFrissoGRomeoE, et al.
Efficacy of pharmacological treatment and genetic characterization in early diagnosed patients affected by long QT syndrome with impaired AV conduction. Int J Cardiol2011;
149: 109–113.
17.
CarsanaAFrissoGTremolaterraMR, et al.
A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene. An analysis of 93 families from Southern Italy. J Mol Diagnostics 2007;
9: 64–69.
18.
LimongelliGMondaETramonteS, et al.
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy. Int J Cardiol2020;
299: 186–191.
19.
LombardoBD'ArgenioVMondaE, et al.
Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome. Mol Genet Genomic Med2020: e1260. DOI: 10.1002/mgg3.1260
20.
D’ArgenioVFrissoGPreconeV, et al.
DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies. J Mol Diagnostics2014;
16: 32–44.
21.
RichardsSAzizNBaleS, et al.
Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med2015;
17: 405–424.
22.
Authors/Task Force members, ElliottPMAnastasakisA, et al.
2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Hear J2014; 35: 2733–2779.
23.
PrioriSGWildeAAHorieM, et al.
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm2013;
10: 1932–1963.
24.
BozkurtBColvinMCookJ, et al.
Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association.Circulation2016;
134: e579–e646.
25.
MarcusFIMcKennaWJSherrillD, et al.
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur Heart J2010;
31: 806–814.
26.
JenniROechslinESchneiderJ, et al.
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: A step towards classification as a distinct cardiomyopathy. Heart2001;
86: 666–671.
27.
LimongelliGNunziatoMMazzaccaraC, et al. Genotype-phenotype correlation: A triple DNA mutational event in a boy entering sport conveys an additional pathogenicity risk. Genes2020; 11: 524.
28.
NiebauerJBörjessonMCarreF, et al.
Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019;
26: 1549–1555.
29.
BorjessonMDellborgMNiebauerJ, et al.
Brief recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: Summary of a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2020;
27: 770–776.
30.
La GercheATaylorAJPriorDL.Athlete’s heart: The potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging 2009;
2: 350–363.
31.
CorradoDBassoCPaveiA, et al.
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc2006;
296: 1593–1601.
32.
LimongelliFMD’AponteALimongelliG, et al.
Epidemiologic study on a population of young athletes of an entire Italian region. Preliminary results of the ‘osservatorio regionale di Medicina dello Sport della Regione Campania’. Med Sport (Roma)2007;
60: 87–99.
33.
CalòLMartinoATranchitaE, et al.
Electrocardiographic and echocardiographic evaluation of a large cohort of peri-pubertal soccer players during pre-participation screening. Eur J Prev Cardiol2019;
26: 1444–1455.
34.
PellicciaADi PaoloFMQuattriniFM, et al.
Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med2008;
358: 152–161.
35.
SheikhNPapadakisMWilsonM, et al.
Diagnostic yield of genetic testing in young athletes with t-wave inversion. Circulation2018;
138: 1184–1194.
36.
GrunerCCareMSiminovitchK, et al.
Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circ Cardiovasc Genet2011;
4: 288–295.
37.
ChungHKimJMinP, et al.
Different contribution of sarcomere and mitochondria related gene mutations to hypertrophic cardiomyopathy. J Am Coll Cardiol2018;
71: A901.
38.
Lafreniere-RoulaMBolkierYZahavichL, et al.
Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?Eur Heart J2019;
40: 3672–3681.
39.
CorradoDBassoCSchiavonM, et al.
Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol2008;
52: 1981–1989.
40.
PrioriSGBlomström-LundqvistCMazzantiA, et al.
2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J2015;
36: 2793–2867.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
